|
HY-100370-1mL
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-121119-10mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-100mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-25mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-5mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-50mg
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-121119-1mL
|
MedChemexpress LLC
|
MRS 1523 [CAS 212329-37-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13104-10mg
|
MedChemexpress LLC
|
MRS 2578 [CAS 711019-86-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13104-5mg
|
MedChemexpress LLC
|
MRS 2578 [CAS 711019-86-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13104-50mg
|
MedChemexpress LLC
|
MRS 2578 [CAS 711019-86-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13104-1mL
|
MedChemexpress LLC
|
MRS 2578 [CAS 711019-86-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-124543-10mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-100mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-25mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-5mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-50mg
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-124543-1mL
|
MedChemexpress LLC
|
MRS-1191 [CAS 185222-90-6] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103190-10mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-100mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-25mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-5mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103190-50mg
|
MedChemexpress LLC
|
MRS1220 [CAS 183721-15-5]
|
|
Cancer-programmed cell death
|
|
|
HY-103174-10mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103174-5mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103186-10mg
|
MedChemexpress LLC
|
MRS-1706 [CAS 264622-53-9]
|
|
COVID-19-immunoregulation
|
|
